Home › Diffuse Large B-Cell Lymphoma › Utah › Salt Lake City

Pag-aaral pangklinika para sa Diffuse Large B-Cell Lymphoma sa Salt Lake City, UT

Isang pag-aaral para sa Diffuse Large B-Cell Lymphoma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Salt Lake City. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL

Nagre-recruitPhase 2

Huntsman Cancer Institute, University of Utah, Salt Lake City
Intermountain Health LDS Hospital, Salt Lake City

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT06500273

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

Nagre-recruitPhase 1

Intermountain Healthcare, Salt Lake City

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07101328

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

Nagre-recruitPhase 1/2

Intermountain - Primary Children's Hospital ( Site 1014), Salt Lake City

6 Months – 25 Years · Lahat ng kasarian · Na-update Set 17, 2026 · NCT06395103

Pilot Study of Anti-CD19 Chimeric Antigen Receptor T Cells (CAR-T Cells) for the Treatment of Relapsed/Refractory CD19+ Malignancies

Nagre-recruitPhase 1

Huntsman Cancer Institute, Salt Lake City

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 26, 2026 · NCT06227026

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

Nagre-recruitPhase 1/2

Huntsman Cancer Institute, Salt Lake City
Intermountain Healthcare, Salt Lake City

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT05826535

A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

Nagre-recruitPhase 3

Intermountain Healthcare, Salt Lake City

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 4, 2026 · NCT07188558

Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma

Nagre-recruitPhase 1

Huntsman Cancer Institute, University of Utah, Salt Lake City

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 10, 2026 · NCT05077527

External Beam Radiotherapy Followed by Bispecific Antibody Therapy for Relapsed/Refractory DLBCL

Nagre-recruitPhase 1

Huntsman Cancer Institute at University of Utah, Salt Lake City

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 4, 2026 · NCT07528352

A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies

Nagre-recruitPhase 1

Huntsman Cancer Institute, University of Utah, Salt Lake City

Edad 18 pataas · Lahat ng kasarian · Na-update Mar 20, 2026 · NCT04830137

Study of Oral Administration of LP-168 in Patients With Relapsed or Refractory B-cell Malignancies.

Nagre-recruitPhase 1

Huntsman Cancer Institute, University of Utah, Salt Lake City

Edad 18 pataas · Lahat ng kasarian · Na-update Peb 13, 2026 · NCT04775745

Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment

Nagre-recruitPhase 2

Huntsman Cancer Institute/University of Utah, Salt Lake City

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 20, 2025 · NCT05890352

Epcoritamab Compared to Observation for Treating B-cell Lymphoma Patients Not in Complete Remission After CD19-directed CAR-T Therapy

Nagre-recruitPhase 2

Huntsman Cancer Institute/University of Utah, Salt Lake City

Edad 18 pataas · Lahat ng kasarian · Na-update Set 26, 2024 · NCT06238648

Pag-aaral para sa Diffuse Large B-Cell Lymphoma sa ibang lungsod

Iba pang pag-aaral sa Salt Lake City

Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.